Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kabi was a pioneering Swedish pharmaceutical company, founded in 1931, that became a global leader in blood plasma products, parenteral nutrition, and recombinant DNA technology. The company is most famous for developing Genotropin, the first recombinant human growth hormone, and for its leadership in clinical nutrition with products like Intralipid. Following a series of mergers, it became Kabi Pharmacia in 1990. In 1999, its infusion and nutrition business was acquired by Fresenius to form Fresenius Kabi, while its other pharmaceutical assets were integrated into Pharmacia (now part of Pfizer). Today, the "Legacy Kabi" name is often associated with the historical innovation and manufacturing sites in Sweden, particularly in Uppsala and Stockholm.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Legacy Kabi.